Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika Grant

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Dermatology|March 19, 2011
Ustekinumab: when everything else fails?Magalys Vitiello, Annika Grant, Francisco A Kerdel
International Journal of Dermatology|December 7, 2010
A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativaMasahiro Amano, Annika Grant, Francisco A Kerdel
International Journal of Dermatology|July 26, 2011
Human T-lymphotropic virus 1 (HTLV-1) infection--dermatological implicationsMasahiro Amano, Mitsuru Setoyama, Annika Grant, et al.
Journal of the American Academy of Dermatology|February 2, 2010
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trialAnnika Grant, Tayler Gonzalez, Michael O Montgomery, et al.
Journal of Drugs in Dermatology : JDD|August 4, 2012
Open label study to evaluate the efficacy of re-treatment with etanercept in patients with psoriasisAdriana Abuchar, Magalys Vitiello, Carlos Ricotti, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Dermatology|March 19, 2011
Ustekinumab: when everything else fails?Magalys Vitiello, Annika Grant, Francisco A Kerdel
International Journal of Dermatology|December 7, 2010
A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativaMasahiro Amano, Annika Grant, Francisco A Kerdel
International Journal of Dermatology|July 26, 2011
Human T-lymphotropic virus 1 (HTLV-1) infection--dermatological implicationsMasahiro Amano, Mitsuru Setoyama, Annika Grant, et al.
Journal of the American Academy of Dermatology|February 2, 2010
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trialAnnika Grant, Tayler Gonzalez, Michael O Montgomery, et al.
Journal of Drugs in Dermatology : JDD|August 4, 2012
Open label study to evaluate the efficacy of re-treatment with etanercept in patients with psoriasisAdriana Abuchar, Magalys Vitiello, Carlos Ricotti, et al.
Pageof 1